Mount Sinai Health System, Inc.'s Form 4 filing
GeneDx Holdings Corp. (WGS) · filed Nov 19, 2024
- Accession no.
- 0000950170-24-128961
- Filed
- Nov 19, 2024, 8:00 PM ET
- Trade date
- Nov 15-18, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $10.4M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mount Sinai Health System, Inc.CIK 0001883135 | 10% Owner |
| Icahn School Of Medicine At Mount SinaiCIK 0001883139 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Class A Common Stock | SSaleDisposed | −20,359 | $69.78 | −$1,420,663.24 | 2,846,474 | Direct | |
| Nov 18, 2024 | Class A Common Stock | SSaleDisposed | −126,782 | $70.78 | −$8,973,059.44 | 2,719,692 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.